On Wednesday, G-III Apparel Group, Ltd. (NASDAQ:GIII)’s shares inclined 11.75% to $67.15.
G-III Apparel Group, Ltd. (GIII) declared that administration will deliver a presentation on behalf of the Company at the 35th Annual Piper Jaffray Consumer Conference being held at The New York Palace in New York City. The presentation will be webcast live at 2:55 p.m. EDT on Wednesday, June 10, 2015 at ir.g-iii.com in the “Events & Presentations” section.
G-III Apparel Group, Ltd. designs, manufactures, and markets woman’s and men’s apparel. It operates through three segments: Licensed Products, Non-Licensed Products, and Retail Operations. The company’s products comprise outerwear, dresses, sportswear, swimwear, women’s suits, and woman’s performance wear. It also markets footwear, luggage and woman’s handbags, small leather goods, and cold weather accessories.
Devon Energy Corp (NYSE:DVN)’s shares dropped -1.42% to $63.91.
Devon Energy Corp (DVN) declared that its board of directors declared a quarterly cash dividend on Devon’s common stock for the third quarter of 2015. The dividend is payable on Sept. 30, 2015, at a rate of $0.24 per share based on a record date of Sept. 15, 2015.
Devon Energy Corporation, an independent energy company, primarily engages in the exploration, development, and production of oil, natural gas, and natural gas liquids (NGLs) in the United States and Canada. It holds interests in various properties located in Anadarko Basin, Barnett Shale, Eagle Ford, Mississippian-Woodford Trend, Permian Basin, and Rockies in the United States, in addition to in the Jackfish and Pike heavy oil projects located in Alberta, Canada.
At the end of Wednesday’s trade, Peregrine Pharmaceuticals (NASDAQ:PPHM)‘s shares surged 2.84% to $1.45.
Peregrine Pharmaceuticals (PPHM) offered a corporate update on its immuno-oncology pipeline, its wholly-owned contract manufacturing business, Avid Bioservices, in addition to anticipated forthcoming milestones. This update outlines the expansion of the bavituximab clinical pipeline with a focus on exploring expanded indications and combinations in lung and breast cancers. These new trials build on recently published clinical data of bavituximab in combination with paclitaxel in HER2 negative breast cancer and clinical translational and preclinical data presented at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting that support the potential combination of bavituximab with the anti-PD-1 checkpoint inhibitor, nivolumab (marketed as Opdivo(R)). These clinical trials are predictable to start enrollment later this year.
Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in the research and development of novel monoclonal antibodies for the treatment and diagnosis of cancer in the United States. Its lead immunotherapy candidate, bavituximab, is in Phase III development for the treatment of second-line non-small cell lung cancer together with various investigator-sponsored trials evaluating other treatment combinations and additional oncology indications.
Kroger Co (NYSE:KR), ended its Wednesday’s trading session with 0.40% gain, and closed at $72.59.
Kroger Co (KR) declared that the company’s innovative electronic temperature monitoring project was named a winner of the 2015 CIO 100 Award by International Data Group’s CIO Magazine.
Kroger’s electronic temperature monitoring initiative, FAST (Food at Safe Temperature) Alerts, tracks cold and frozen food case temperatures and notifies store associates of temperature changes. Using interactive sensors that are connected through an in-store network, FAST Alerts assists ensure that fresh foods remain fresher, longer by making real-time temperature checks of produce, meat, deli and frozen food products. The technology also eliminates the need for manual temperature logs.
The program is the result of partnership between Kroger’s Facility Engineering, Food Safety, Technology, Pharmacy, Merchandising and Retail Operations departments, in addition to store leaders and associates.
Kroger and other winning companies will be recognized at The CIO 100 Symposium & Awards Ceremony in August in Colorado Springs, Colorado.
The Kroger Co., together with its auxiliaries, operates as a retailer in the United States and internationally. It also manufactures and processes food for sale in its supermarkets. The company operates retail food and drug stores, multi-department stores, jewelry stores, and convenience stores.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
